Litigation Details for Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. (Fed. Cir. 2025)
✉ Email this page to a colleague
Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. (Fed. Cir. 2025)
| Docket | ⤷ Start Trial | Date Filed | 2025-06-23 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 10,028,944; 10,449,185; 10,517,860; 10,646,480; 10,849,891; 10,953,000; 11,452,721; 7,601,740; 7,659,285; 7,732,615; 7,816,383; 7,858,789; 7,923,564; 8,110,574; 8,618,130; 8,921,393; 9,566,271 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd.
Details for Acadia Pharmaceuticals Inc. v. Aurobindo Pharma Ltd. (Fed. Cir. 2025)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2025-06-23 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
